Literature DB >> 9095171

HIV accessory proteins as therapeutic targets.

R H Miller1, N Sarver.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9095171     DOI: 10.1038/nm0497-389

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1.

Authors:  F M Marassi; C Ma; H Gratkowski; S K Straus; K Strebel; M Oblatt-Montal; M Montal; S J Opella
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1.

Authors:  Che Ma; Francesca M Marassi; David H Jones; Suzana K Straus; Stephan Bour; Klaus Strebel; Ulrich Schubert; Myrta Oblatt-Montal; Mauricio Montal; Stanley J Opella
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

3.  Application of solid-state NMR restraint potentials in membrane protein modeling.

Authors:  Jinhyuk Lee; Jianhan Chen; Charles L Brooks; Wonpil Im
Journal:  J Magn Reson       Date:  2008-04-18       Impact factor: 2.229

4.  On the solution conformation and dynamics of the HIV-1 viral infectivity factor.

Authors:  Sean R Marcsisin; Purushottam S Narute; Lori A Emert-Sedlak; Marek Kloczewiak; Thomas E Smithgall; John R Engen
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

5.  The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity.

Authors:  Y L Chen; D Trono; D Camaur
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Authors:  Sang Ho Park; Stanley J Opella
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

7.  Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.

Authors:  M Gasmi; J Glynn; M J Jin; D J Jolly; J K Yee; S T Chen
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.

Authors:  U Schubert; S Bour; R L Willey; K Strebel
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.

Authors:  Pavel Bostik; Geraldine L Dodd; Francois Villinger; Ann E Mayne; Aftab A Ansari
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Analysis of dinucleotide signatures in HIV-1 subtype B genomes.

Authors:  Aridaman Pandit; Jyothirmayi Vadlamudi; Somdatta Sinha
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.